{"id":"scaling-07n","title":"F2: Curve fitting and statistical analysis","description":"Fit mathematical models to ESP data. Models: simple exponential, piecewise exponential, Wright's Law, logistic curves. Output: parameter estimates, doubling times, extrapolations to ESP=1. Software: Python scipy/statsmodels.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:14.855213-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:14.855213-05:00","dependencies":[{"issue_id":"scaling-07n","depends_on_id":"scaling-w3e","type":"blocks","created_at":"2026-02-01T10:24:23.492808-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-07n","depends_on_id":"scaling-qa6","type":"blocks","created_at":"2026-02-01T10:24:23.738304-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-07n","depends_on_id":"scaling-8sa","type":"blocks","created_at":"2026-02-01T10:24:23.979464-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-07n","depends_on_id":"scaling-1da","type":"blocks","created_at":"2026-02-01T10:24:24.206535-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-07n","depends_on_id":"scaling-x92","type":"blocks","created_at":"2026-02-01T10:24:24.456342-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-07n","depends_on_id":"scaling-45k","type":"blocks","created_at":"2026-02-01T10:24:24.70565-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-07n","depends_on_id":"scaling-7m3","type":"blocks","created_at":"2026-02-01T10:24:24.955251-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-07n","depends_on_id":"scaling-olt","type":"blocks","created_at":"2026-02-01T10:24:25.19637-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-07n","depends_on_id":"scaling-2v2","type":"blocks","created_at":"2026-02-01T10:24:25.414449-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-0qz","title":"B1: Domestication timeline compilation","description":"Compile domestication timelines, population sizes, trait fixation times for key species (wheat/maize, dogs, cattle). Sources: archaeological/genetic literature, zooarchaeology, ancient DNA studies.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:20.388431-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:20.388431-05:00"}
{"id":"scaling-0zk","title":"G2: Methods drafting","description":"Draft methods section (~1000 words): data sources and extraction, standardization procedures, curve fitting methodology, sensitivity analysis approach.","status":"open","priority":2,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:27.417012-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:27.417012-05:00","dependencies":[{"issue_id":"scaling-0zk","depends_on_id":"scaling-07n","type":"blocks","created_at":"2026-02-01T10:24:14.001149-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-1am","title":"D1: Directed evolution data compilation","description":"Compile library sizes screened, rounds of selection, hit rates by method from Arnold lab publications and directed evolution reviews. Include historical data and ML-guided design outcomes.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:23.964586-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:23.964586-05:00"}
{"id":"scaling-1da","title":"C3: Speed breeding literature review","description":"Review speed breeding protocols and efficiency gains. Sources: Watson et al., Hickey et al. Quantify cycle time reductions and impact on ESP.","status":"open","priority":2,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:48.365032-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:48.365032-05:00","dependencies":[{"issue_id":"scaling-1da","depends_on_id":"scaling-erk","type":"blocks","created_at":"2026-02-01T10:23:50.675236-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-2v2","title":"E4: Gene therapy/CAR-T data","description":"Compile gene therapy and CAR-T outcomes. Include Kymriah, Yescarta complete response rates, Zolgensma, Luxturna efficacy. Expected ESP range: 1-5.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:11.007658-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:11.007658-05:00","dependencies":[{"issue_id":"scaling-2v2","depends_on_id":"scaling-udm","type":"blocks","created_at":"2026-02-01T10:24:05.240223-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-45k","title":"D3: CRISPR efficiency data","description":"Compile CRISPR edit success rates by organism, off-target rates over time, time from design to validated edit from methodology literature.","status":"open","priority":2,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:25.922836-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:25.922836-05:00"}
{"id":"scaling-7m3","title":"E2: FDA approval package analysis","description":"Analyze FDA drug approval packages for pivotal trial sample sizes over time, response rates by therapeutic area. Track evolution of trial sizes and NNT values.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:51.944631-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:51.944631-05:00","dependencies":[{"issue_id":"scaling-7m3","depends_on_id":"scaling-udm","type":"blocks","created_at":"2026-02-01T10:23:54.370924-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-8sa","title":"C2: CGIAR/CIMMYT historical analysis","description":"Analyze historical CGIAR/CIMMYT breeding records. Calculate ESP_breeding = (Crosses × Progeny × Selection cycles) / Released varieties. Reference: Evenson \u0026 Gollin 2003, Duvick 2005.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:46.795919-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:46.795919-05:00","dependencies":[{"issue_id":"scaling-8sa","depends_on_id":"scaling-erk","type":"blocks","created_at":"2026-02-01T10:23:49.147821-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-92g","title":"F3: Visualization development","description":"Create figures: ESP framework diagram, ESP vs time for each domain, unified curve overlay, doubling time analysis, projection to ESP=1. Target: 8 main figures per paper outline.","status":"open","priority":2,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:16.545665-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:16.545665-05:00","dependencies":[{"issue_id":"scaling-92g","depends_on_id":"scaling-07n","type":"blocks","created_at":"2026-02-01T10:24:10.678129-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-cwh","title":"A1: Evolution literature review","description":"Compile quantitative data on mutation rates, population sizes, and phenotypic innovation rates in natural evolution. Deliverables: annotated bibliography (20-30 papers), data table with taxon/mutation rate/population size/generation time/innovations, summary of major transitions framework.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:18.72459-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:18.72459-05:00"}
{"id":"scaling-dei","title":"G3: Results drafting","description":"Draft results section (~3000 words): Results by domain (evolution, domestication, breeding, biotech, clinical), unified curve construction.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:29.058487-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:29.058487-05:00","dependencies":[{"issue_id":"scaling-dei","depends_on_id":"scaling-07n","type":"blocks","created_at":"2026-02-01T10:24:27.326769-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-dei","depends_on_id":"scaling-92g","type":"blocks","created_at":"2026-02-01T10:24:27.557632-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-erk","title":"C1: Breeding program data acquisition","description":"Acquire breeding program records from CGIAR archives, university programs, USDA. Target programs: CIMMYT wheat/maize, US soybean breeding, dairy cattle genetic improvement. Collect crosses, selections, outcomes, variety release timelines.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:22.075325-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:22.075325-05:00"}
{"id":"scaling-inp","title":"G1: Introduction drafting","description":"Draft introduction (~1000 words): Moore's Law of biology quest, why previous attempts failed, search efficiency insight, ESP framework overview.","status":"open","priority":2,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:18.276393-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:18.276393-05:00","dependencies":[{"issue_id":"scaling-inp","depends_on_id":"scaling-07n","type":"blocks","created_at":"2026-02-01T10:24:12.533646-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-lg5","title":"G4: Discussion drafting","description":"Draft discussion (~1500 words): biotech investment implications, clinical trial design implications, N=1 horizon, limitations, future directions.","status":"open","priority":2,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:30.837301-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:30.837301-05:00","dependencies":[{"issue_id":"scaling-lg5","depends_on_id":"scaling-dei","type":"blocks","created_at":"2026-02-01T10:24:29.075847-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-olt","title":"E3: Precision medicine trial outcomes","description":"Compile response rates for biomarker-stratified treatments. Key trials: IMPACT, NCI-MATCH, TAPUR, basket/umbrella trials. Track biomarker-drug pairs: HER2/trastuzumab, EGFR/gefitinib, ALK/crizotinib, BRAF/vemurafenib, BCR-ABL/imatinib, PD-L1/checkpoint inhibitors.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:09.448147-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:09.448147-05:00","dependencies":[{"issue_id":"scaling-olt","depends_on_id":"scaling-udm","type":"blocks","created_at":"2026-02-01T10:24:03.634247-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-qa6","title":"B2: Archaeological crop/animal data","description":"Extract detailed archaeological data on crop yields, animal trait changes during domestication. Calculate ESP_domestication values. Expected ESP range: 10^6 - 10^10.","status":"open","priority":2,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:45.301167-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:45.301167-05:00","dependencies":[{"issue_id":"scaling-qa6","depends_on_id":"scaling-0qz","type":"blocks","created_at":"2026-02-01T10:23:47.361246-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-udm","title":"E1: Historical NNT database construction","description":"Build comprehensive database of Number Needed to Treat values across therapeutic areas and time periods. Sources: TheNNT.com, Cochrane reviews, Bandolier, FDA packages. Priority areas: cardiovascular, infectious disease, oncology, diabetes, neurological.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:27.51629-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:27.51629-05:00"}
{"id":"scaling-una","title":"F1: Phenotype complexity scoring system","description":"Develop Phenotypic Complexity Score (PCS) normalization. Levels 1-7: single trait shift (1) to major transition (64). Alternative: information-theoretic PCS = log₂(distinguishable phenotypic states).","status":"open","priority":2,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:23:12.774823-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:23:12.774823-05:00","dependencies":[{"issue_id":"scaling-una","depends_on_id":"scaling-cwh","type":"blocks","created_at":"2026-02-01T10:24:08.203062-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-una","depends_on_id":"scaling-0qz","type":"blocks","created_at":"2026-02-01T10:24:08.449779-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-una","depends_on_id":"scaling-erk","type":"blocks","created_at":"2026-02-01T10:24:08.724174-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-una","depends_on_id":"scaling-1am","type":"blocks","created_at":"2026-02-01T10:24:08.96781-05:00","created_by":"Jake Feala"},{"issue_id":"scaling-una","depends_on_id":"scaling-udm","type":"blocks","created_at":"2026-02-01T10:24:09.206541-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-w3e","title":"A2: Major transitions data extraction","description":"Extract quantitative data on major evolutionary transitions using Maynard Smith \u0026 Szathmáry framework. Calculate ESP for major phenotypic innovations. Expected ESP range: 10^15 - 10^20.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:43.812177-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:43.812177-05:00","dependencies":[{"issue_id":"scaling-w3e","depends_on_id":"scaling-cwh","type":"blocks","created_at":"2026-02-01T10:23:45.260999-05:00","created_by":"Jake Feala"}]}
{"id":"scaling-x92","title":"D2: ML-guided protein design outcomes","description":"Compile ML-guided protein design success rates (2020-present). Track ESP trajectory: Classic DE 10^5-10^8, Structure-guided 10^3-10^5, ML-guided 10^1-10^3, Frontier ML 10^0-10^1.","status":"open","priority":1,"issue_type":"task","owner":"jfeala@flagshippioneering.com","created_at":"2026-02-01T10:22:49.964234-05:00","created_by":"Jake Feala","updated_at":"2026-02-01T10:22:49.964234-05:00","dependencies":[{"issue_id":"scaling-x92","depends_on_id":"scaling-1am","type":"blocks","created_at":"2026-02-01T10:23:52.564215-05:00","created_by":"Jake Feala"}]}
